Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel G Johnson

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chest|January 17, 2008
Outcomes associated with combined antiplatelet and anticoagulant therapySamuel G Johnson, Kristina Rogers, Thomas Delate, et al.
Journal of Managed Care & Specialty Pharmacy|June 26, 2015
Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary InterventionSamuel G Johnson, Don Gruntowicz, Theresa Chua, et al.
Chest|May 15, 2007
Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management serviceSamuel G Johnson, Daniel M Witt, Todd R Eddy, et al.
Journal of the American Pharmacists Association : Japha|July 21, 2019
Exploring the relationship between examination pass rates and eligibility pathways among pharmacist candidates for initial board certificationSamuel G Johnson, Timothy Muckle, Siddiq Kassam, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapySamuel G Johnson, Daniel M Witt, Thomas Delate, et al.
The Mental Health Clinician|November 26, 2021
Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scoresTimothy J Muckle, Julie Dopheide, Kelly Gable, et al.
Journal of Thrombosis and Thrombolysis|May 2, 2009
Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary interventionKari L Olson, Thomas Delate, Samuel G Johnson, et al.
Thrombosis Research|March 20, 2014
A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertensionAdriane N Irwin, Samuel G Johnson, Brigitte R Joline, et al.
The American Journal of Managed Care|November 10, 2023
Rituximab reference vs biosimilar utilization for oncology vs nononcology indicationsBonnie A Labdi, Rim A Elbeshbeshy, Michelle Winkler, et al.
Thrombosis Research|October 20, 2015
Thrombophilia testing patterns amongst patients with acute venous thromboembolismMelissa R Meyer, Daniel M Witt, Thomas Delate, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chest|January 17, 2008
Outcomes associated with combined antiplatelet and anticoagulant therapySamuel G Johnson, Kristina Rogers, Thomas Delate, et al.
Journal of Managed Care & Specialty Pharmacy|June 26, 2015
Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary InterventionSamuel G Johnson, Don Gruntowicz, Theresa Chua, et al.
Chest|May 15, 2007
Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management serviceSamuel G Johnson, Daniel M Witt, Todd R Eddy, et al.
Journal of the American Pharmacists Association : Japha|July 21, 2019
Exploring the relationship between examination pass rates and eligibility pathways among pharmacist candidates for initial board certificationSamuel G Johnson, Timothy Muckle, Siddiq Kassam, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapySamuel G Johnson, Daniel M Witt, Thomas Delate, et al.
The Mental Health Clinician|November 26, 2021
Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scoresTimothy J Muckle, Julie Dopheide, Kelly Gable, et al.
Journal of Thrombosis and Thrombolysis|May 2, 2009
Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary interventionKari L Olson, Thomas Delate, Samuel G Johnson, et al.
Thrombosis Research|March 20, 2014
A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertensionAdriane N Irwin, Samuel G Johnson, Brigitte R Joline, et al.
The American Journal of Managed Care|November 10, 2023
Rituximab reference vs biosimilar utilization for oncology vs nononcology indicationsBonnie A Labdi, Rim A Elbeshbeshy, Michelle Winkler, et al.
Thrombosis Research|October 20, 2015
Thrombophilia testing patterns amongst patients with acute venous thromboembolismMelissa R Meyer, Daniel M Witt, Thomas Delate, et al.
Pageof 3